Neoadjuvant Chemoradiotherapy Combined With Perioperative Toripalimab in Locally Advanced Esophageal Cancer

Clinical trial NCT04437212 · UNKNOWN

Trial details

NCT number: NCT04437212
Sponsor: RenJi Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Esophageal Squamous Cell Cancer

Start date: 2020-07-01
Primary completion: 2021-12-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.